Zobrazeno 1 - 8
of 8
pro vyhledávání: '"V B Nikitina"'
Publikováno v:
Бюллетень сибирской медицины, Vol 19, Iss 1, Pp 21-28 (2020)
The aim of the study was to investigate the clinical phenomena of asthenia and subjective well-being of women aged 40–65 with non-psychotic mental disorders.Materials and methods. A complete examination of 204 women aged 40–65 who received treatm
Externí odkaz:
https://doaj.org/article/3e436625d76047ccb385cdcabfd88cc9
Autor:
T. P. Vetlugina, V. D. Prokopieva, E. V. Epimakhova, A. S. Boiko, V. B. Nikitina, N. A. Bokhan
Publikováno v:
Bulletin of Experimental Biology and Medicine. 173:151-154
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6729f32585da7e45481ad4f479b215ac
https://doi.org/10.1007/s10517-022-05511-5
https://doi.org/10.1007/s10517-022-05511-5
Autor:
O E Perchatkina, T P Klyushnik, T.P. Vetlugina, O.A. Lobacheva, L. V. Androsova, V B Nikitina, Otman In
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 120:76
To determine factors of innate and acquired immunity in adaptation disorders with a predominance of asthenic or anxiety-depressive syndrome.Twenty-five patients with ICD-10 diagnosis of «Adaptation Disorders» (F43.2), including 9 with asthenic synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d895f856f6d99bdeccddd4c9329d78fe
https://doi.org/10.17116/jnevro202012008176
https://doi.org/10.17116/jnevro202012008176
Autor:
T P Vetlugina, V B Nikitina, Cheĭdo Ma, Idova Gv, Al'perina El, Arkadiy V. Semke, O A Lobacheva, E. N. Zhukova
Publikováno v:
Scopus-Elsevier
Study of immunomodulatory effect of atypical antipsychotic amisulpride has revealed a positive clinical effect after 6-week therapy of schizophrenic patients regarding both positive and negative symptoms. A decrease in activity of humoral immunity fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a8d9e176b63fa5d72f9bf3cdae2597b
https://doi.org/10.15690/vramn.v67i12.475
https://doi.org/10.15690/vramn.v67i12.475
Autor:
T P, Vetlugina, V B, Nikitina, S A, Sergeeva, M M, Axenov, O A, Lobacheva, D N, Savochkina, E M, Epanchintseva, N A, Bokhan
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (4)
Our aim was to assess effect of antiasthenic drug adamantilbromphenylamine on the immune system and symptoms of asthenia in patients with non-psychotic mental disorders and to reveal possible criteria for prediction of treatment efficiency.Uncontroll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::37c2e702e1bd6dfae33359c3e185a21d
https://pubmed.ncbi.nlm.nih.gov/26710531
https://pubmed.ncbi.nlm.nih.gov/26710531
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 118:59
To determine immunophenotypes of patients with adaptation disorders using cluster analysis. The level of inflammatory markers such as leukocyte elastase (LE) enzyme activity and functional activity of α1-protease inhibitor (α1-PI) were used as a cl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e32d7226a464132ca5ed6c146017d064
https://doi.org/10.17116/jnevro20181187159
https://doi.org/10.17116/jnevro20181187159
Autor:
T P Klyushnik, M M Aksenov, Nikolay A. Bokhan, S A Zozulya, T P Vetlugina, V B Nikitina, L. V. Androsova
Publikováno v:
Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 118:83
To identify inflammatory and autoimmune markers (enzymatic activity of leukocyte elastase (LE), functional α1-proteinase inhibitor (α1-PI), the level of autoantibodies to neurospecific antigens S100b and myelin basic protein (MBP)) as well as phago
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f494879c61003d1378aa9281cefb2af7
https://doi.org/10.17116/jnevro20181183183-88
https://doi.org/10.17116/jnevro20181183183-88
Autor:
T P, Vetlugina, O A, Lobacheva, E L, Al'perina, E N, Zhukova, A V, Semke, V B, Nikitina, M A, Cheĭdo, G V, Idova
Publikováno v:
Vestnik Rossiiskoi akademii meditsinskikh nauk. (12)
Study of immunomodulatory effect of atypical antipsychotic amisulpride has revealed a positive clinical effect after 6-week therapy of schizophrenic patients regarding both positive and negative symptoms. A decrease in activity of humoral immunity fa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::fd5fec4ef3f84b66fbf871493935b7cb
https://pubmed.ncbi.nlm.nih.gov/23530420
https://pubmed.ncbi.nlm.nih.gov/23530420